newsfilter
← Latest News
Business Wire·

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

Portfolio includes PAT devices for real-time process monitoring, control and analysis Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc.